{"id":23278,"date":"2020-07-01T00:00:00","date_gmt":"2020-07-01T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/2020\/07\/01\/un-nouvel-essai-clinique-evaluera-un-traitement-pour-attenuer-les-infections-au-coronavirus-chez-les-personnes-atteintes-de-cancer\/"},"modified":"2020-07-01T00:00:00","modified_gmt":"2020-07-01T05:00:00","slug":"un-nouvel-essai-clinique-evaluera-un-traitement-pour-attenuer-les-infections-au-coronavirus-chez-les-personnes-atteintes-de-cancer","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2020\/07\/01\/un-nouvel-essai-clinique-evaluera-un-traitement-pour-attenuer-les-infections-au-coronavirus-chez-les-personnes-atteintes-de-cancer\/","title":{"rendered":"Un nouvel essai clinique \u00e9valuera un traitement pour att\u00e9nuer les infections au coronavirus chez les personnes atteintes de cancer"},"content":{"rendered":"<p>Un nouvel&nbsp;<a href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04442048?term=NCT04442048&amp;draw=2&amp;rank=1\" target=\"_blank\" rel=\"noopener\">essai clinique<\/a>&nbsp;men&eacute; par le Groupe canadien des essais sur le cancer (GCEC), qui est financ&eacute; par la Soci&eacute;t&eacute; canadienne du cancer (SCC), est le premier au monde &agrave; &eacute;valuer un traitement immunostimulant pour r&eacute;duire les sympt&ocirc;mes et pr&eacute;venir les cas graves de COVID-19 et d&rsquo;autres infections respiratoires graves chez les personnes atteintes de cancer en particulier. Pour lire la suite, cliquez <a href=\"https:\/\/www.cancer.ca\/fr-ca\/about-us\/for-media\/media-releases\/national\/2020\/cctg-covid-trial\/?region=on\" target=\"_blank\" rel=\"noopener\"><strong>ici<\/strong><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Un nouvel&nbsp;essai clinique&nbsp;men&eacute; par le Groupe canadien des essais sur le cancer (GCEC), qui est financ&eacute; par la Soci&eacute;t&eacute; canadienne du cancer (SCC), est le premier au monde &agrave; &eacute;valuer un traitement immunostimulant pour r&eacute;duire les sympt&ocirc;mes et pr&eacute;venir les cas graves de COVID-19 et d&rsquo;autres infections respiratoires graves chez les personnes atteintes de cancer [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[72],"tags":[],"class_list":["post-23278","post","type-post","status-publish","format-standard","hentry","category-actualites-et-nouvelles-au-sujet-de-la-covid-19"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23278","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=23278"}],"version-history":[{"count":0,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23278\/revisions"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=23278"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=23278"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=23278"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}